Hospira Symbiq One-Channel and Two-Channel Infusers: Class I Recall - Motor Encoder Failures
MedSun: Newsletter #55, December 2010

FDA MedWatch Safety Alert

FDA and Hospira notified healthcare professionals of a Class 1 recall of these infusion pump products due to motor encoder failures in the pumping mechanism that causes the infuser to cease operation. Delay or interruption of therapy may result in serious injury or death. Until Hospira can upgrade all Symbiq pumping mechanisms, corrected loaner pumps will be provided at no cost to customers for critical care areas. Until loaner or corrected pumps are in place in critical care areas, Hospira urges customers to consider an alternate method to administer therapy.

Additional Information:

FDA MedWatch Safety Alert. Hospira Symbiq One-Channel and Two-Channel Infusers: Class I Recall - Motor Encoder Failures. November 4, 2010.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm232568.htm


MedSun Newsletters are available at www.fda.gov/cdrh/medsun